MedPath

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

Completed
Conditions
Interstitial Lung Disease
Registration Number
NCT02636452
Lead Sponsor
Wissenschaftliches Institut Bethanien e.V
Brief Summary

In patients with Interstitial lung diseases (ILD) dyspnea is the most often symptom. Pulmonary lung function tests often do not Show the dyspnea. Aim of the study is to evaluate cardiopulmonary exercise testing concerning therapeutic Monitoring in ILD.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • informed consent provided
  • ILD
Exclusion Criteria
  • no informed consent
  • no ILD

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alveolar-arterial oxygen partial pressure difference (AaDO2) in cardipulmonary exercise testing in ILDquarterly, three years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep and Respiratory Medicine

🇩🇪

Solingen, NRW, Germany

Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep and Respiratory Medicine
🇩🇪Solingen, NRW, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.